[go: up one dir, main page]

UA100542C2 - Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba - Google Patents

Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba

Info

Publication number
UA100542C2
UA100542C2 UAA201009196A UAA201009196A UA100542C2 UA 100542 C2 UA100542 C2 UA 100542C2 UA A201009196 A UAA201009196 A UA A201009196A UA A201009196 A UAA201009196 A UA A201009196A UA 100542 C2 UA100542 C2 UA 100542C2
Authority
UA
Ukraine
Prior art keywords
leaves
prophylaxis
treatment
ginkgo biloba
extract made
Prior art date
Application number
UAA201009196A
Other languages
English (en)
Ukrainian (uk)
Inventor
Йоахим ХЕРРМАНН
Роберт Хорр
Original Assignee
Др. Виллмар Швабе Гмбх Энд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39345476&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA100542(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Др. Виллмар Швабе Гмбх Энд Ко. Кг filed Critical Др. Виллмар Швабе Гмбх Энд Ко. Кг
Publication of UA100542C2 publication Critical patent/UA100542C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Изобретение относится к способу лечения и/или профилактики синдрома слабоумия, а также его ранних стадий и предстадий путем введения экстракта, изготовленного из листьев Ginkgo Biloba, как лекарственного средства в дозе от 180 до 300 мг один раз в день.
UAA201009196A 2007-12-21 2008-12-18 Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba UA100542C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07024973.5A EP2072054B1 (de) 2007-12-21 2007-12-21 Verwendung eines Extraktes aus Blättern von Ginkgo biloba
PCT/EP2008/010799 WO2009083162A1 (de) 2007-12-21 2008-12-18 Verwendung eines extraktes aus blättern von ginkgo biloba

Publications (1)

Publication Number Publication Date
UA100542C2 true UA100542C2 (ru) 2013-01-10

Family

ID=39345476

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201009196A UA100542C2 (ru) 2007-12-21 2008-12-18 Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba

Country Status (12)

Country Link
US (1) US20100310653A1 (ru)
EP (2) EP2072054B1 (ru)
JP (1) JP5634268B2 (ru)
KR (1) KR20100124248A (ru)
CN (1) CN101903033A (ru)
BR (1) BRPI0821775A2 (ru)
CA (1) CA2709958C (ru)
ES (1) ES2709633T3 (ru)
HU (1) HUE041715T2 (ru)
RU (1) RU2493865C2 (ru)
UA (1) UA100542C2 (ru)
WO (1) WO2009083162A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2072054B1 (de) 2007-12-21 2018-11-07 Dr. Willmar Schwabe GmbH & Co. KG Verwendung eines Extraktes aus Blättern von Ginkgo biloba
JP5759113B2 (ja) * 2010-06-16 2015-08-05 旭化成ケミカルズ株式会社 エキス末配合錠剤
JP6031662B2 (ja) * 2012-02-29 2016-11-24 株式会社漢方医科学研究所 認知機能低下改善用組成物
CN102846677A (zh) * 2012-08-14 2013-01-02 王青 银杏酚酸在制备治疗皮肤肿瘤的外用制剂中的用途
KR101836801B1 (ko) 2017-02-21 2018-03-12 박용호 인지기능개선 효능을 가진 천연 소재 조성물 및 한과 제조법
JP6904802B2 (ja) * 2017-06-23 2021-07-21 株式会社ファンケル 軽度認知障害改善用の組成物
CN110433157B (zh) * 2018-05-02 2022-10-18 成都百裕制药股份有限公司 银杏萜内酯在制备预防和/或治疗眩晕症的药物中的用途
ES2958082T3 (es) * 2019-01-15 2024-02-01 Dr Willmar Schwabe Gmbh & Co Kg Procedimiento para la producción de comprimidos de fácil toma con extracto seco de hojas de Ginkgo biloba
US20220280586A1 (en) * 2019-07-19 2022-09-08 Folium Biosciences Europe B.V. Method for extraction
CN110897056B (zh) * 2019-12-30 2023-08-25 内江师范学院 一种银杏叶提取物鱼饲料粘合剂及制备方法和应用
KR20220123272A (ko) * 2020-01-03 2022-09-06 바이오서치 에스.에이. 인지 장애 치료용 조성물
CN116419751A (zh) * 2020-12-11 2023-07-11 成都百裕制药股份有限公司 白果内酯或银杏内酯组合物在制备镇静药物中的应用
JP2023050584A (ja) * 2021-09-30 2023-04-11 旭化成株式会社 錠剤用組成物及び錠剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556552A (en) * 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
DE3940091A1 (de) 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE50101673D1 (de) * 2000-08-17 2004-04-15 Medichemie Ag Ettingen Verwendung von extrakten aus ginkgo biloba-blättern zur traumprovokation
FR2823116B1 (fr) * 2001-04-10 2004-11-19 Sod Conseils Rech Applic Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs
WO2003047511A2 (en) * 2001-11-29 2003-06-12 U.S. Department Of Veterans Affairs Use of gingko biloba extracts to promote neuroprotection and reduce weight loss
SI1559430T1 (sl) * 2004-01-29 2009-08-31 Indena Spa Uporaba kompleksov ginkga za izboljĺ anje kognitivnih funkcij in ublaĺ˝itev duĺ evne izäśrpanosti
KR100623164B1 (ko) * 2004-07-22 2006-09-19 재단법인서울대학교산학협력재단 뇌신경 보호효과를 갖는 신규한 은행잎 엑스를 정제하는방법 및 이를 함유하는 조성물
CN101175506B (zh) * 2005-05-03 2012-06-06 威玛舒培博士两合公司 制备具有降低含量的4’-o-甲基吡哆醇和/或双黄酮的银杏提取物的方法
DE602006002733D1 (de) 2005-05-03 2008-10-23 Schwabe Willmar Gmbh & Co Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an polycyclischen aromatischen kohlenwasserstoffen
DE102005061948A1 (de) 2005-05-03 2006-11-16 Bioplanta Arzneimittel Gmbh Verbessertes Verfahren zur Herstellung von 4'-O-Methylpyridoxin- und/oder Biflavon-armen Ginkgoextrakten
WO2006117168A2 (de) * 2005-05-03 2006-11-09 Dr. Willmar Schwabe Gmbh & Co. Kg Verfahren zur herstellung von ginkgoextrakten mit vermindertem gehalt an unpolaren pflanzeninhaltsstoffen und umweltbedingten unpolaren fremdstoffen
EP2072054B1 (de) 2007-12-21 2018-11-07 Dr. Willmar Schwabe GmbH & Co. KG Verwendung eines Extraktes aus Blättern von Ginkgo biloba

Also Published As

Publication number Publication date
EP3446696A1 (de) 2019-02-27
RU2493865C2 (ru) 2013-09-27
KR20100124248A (ko) 2010-11-26
EP2072054B1 (de) 2018-11-07
EP2072054A1 (de) 2009-06-24
CN101903033A (zh) 2010-12-01
ES2709633T3 (es) 2019-04-17
JP2011506512A (ja) 2011-03-03
JP5634268B2 (ja) 2014-12-03
US20100310653A1 (en) 2010-12-09
CA2709958A1 (en) 2009-07-09
WO2009083162A1 (de) 2009-07-09
RU2010129982A (ru) 2012-01-27
CA2709958C (en) 2016-06-21
BRPI0821775A2 (pt) 2015-06-16
HUE041715T2 (hu) 2019-05-28

Similar Documents

Publication Publication Date Title
UA100542C2 (ru) Способ лечения и/или профилактики синдрома слабоумия экстрактом, изготовленным из листьев ginkgo biloba
TN2012000428A1 (en) Bisaryl-bonded aryltriazolones and use thereof
MX2010006033A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso.
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
MY156777A (en) Substituted 2-acetamido-5-ary1-1,2,4-triazolones and use thereof
UA102065C2 (en) Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
MX2011005865A (es) Clorhidrato de nalmefeno dihidratado.
PH12013501143A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
MX2009000333A (es) Pirrilopirimidinas para composiciones farmaceuticas.
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
TW200736213A (en) Dicarboxylic acid derivatives and their use
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
UA105487C2 (ru) Замещенные дигидропиразолоны как ингибиторы hif-пролил-4-гидроксилазы
WO2009068214A3 (de) Heteroaryl-substituierte piperidine
GEP20115342B (en) New diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
WO2008119457A3 (de) Lactam-substituierte dicarbonsäuren und ihre verwendung
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
IN2012DN00639A (ru)
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
TW200621765A (en) Substituted phenylaminothiazoles and their use
NZ596851A (en) Methods of treating hepatic encephalopathy
UA92861C2 (ru) Фармацевтическая композиция для лечения депрессии и способ ее получения
WO2009142428A3 (en) Pharmaceutical composition for the treatment of premature ejaculation
CL2008000982A1 (es) Compuestos derivados de 5-oxo-isoxazol-carboxamida; proceso de preparacion; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de
DE502007006625D1 (de) 3-cyano-5-thiazaheteroaryl-dihydropyridine und ihrnkungen